| Year |
Citation |
Score |
| 2021 |
Gray R, Patel S, Ives N, Rick C, Woolley R, Muzerengi S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE. Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial. Jama Neurology. PMID 34962574 DOI: 10.1001/jamaneurol.2021.4736 |
0.412 |
|
| 2021 |
Scobie S, Jowett S, Lambe T, Patel S, Woolley R, Ives N, Rick C, Smith C, Brady MC, Clarke C, Sackley C. Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial. Pilot and Feasibility Studies. 7: 154. PMID 34372913 DOI: 10.1186/s40814-021-00888-y |
0.395 |
|
| 2021 |
McIntosh E, Kent S, Gray A, Clarke CE, Williams A, Jenkinson C, Ives N, Patel S, Rick C, Wheatley K, Gray R. Cost-Effectiveness of Dopamine Agonists and Monoamine Oxidase B Inhibitors in Early Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33960511 DOI: 10.1002/mds.28623 |
0.416 |
|
| 2020 |
Sackley CM, Rick C, Au P, Brady MC, Beaton G, Burton C, Caulfield M, Dickson S, Dowling F, Hughes M, Ives N, Jowett S, Masterson-Algar P, Nicoll A, Patel S, et al. A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial. Trials. 21: 436. PMID 32460885 DOI: 10.1186/S13063-020-04354-7 |
0.439 |
|
| 2018 |
Herd CP, Tomlinson CL, Rick C, Scotton WJ, Edwards J, Ives N, Clarke CE, Sinclair A. Botulinum toxins for the prevention of migraine in adults. The Cochrane Database of Systematic Reviews. 6: CD011616. PMID 29939406 DOI: 10.1002/14651858.Cd011616.Pub2 |
0.314 |
|
| 2018 |
Sackley CM, Smith CH, Rick CE, Brady MC, Ives N, Patel S, Woolley R, Dowling F, Patel R, Roberts H, Jowett S, Wheatley K, Kelly D, Sands G, Clarke CE, et al. Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: a pilot randomised controlled trial (PD COMM pilot). Pilot and Feasibility Studies. 4: 30. PMID 29344405 DOI: 10.1186/s40814-017-0222-z |
0.383 |
|
| 2017 |
Markey KA, Ottridge R, Mitchell JL, Rick C, Woolley R, Ives N, Nightingale P, Sinclair AJ. Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial. Jmir Research Protocols. 6: e181. PMID 28923789 DOI: 10.2196/Resprot.7806 |
0.309 |
|
| 2017 |
Masterson-Algar P, Burton CR, Brady MC, Nicoll A, Clarke CE, Rick C, Hughes M, Au P, Smith CH, Sackley CM. The PD COMM trial: a protocol for the process evaluation of a randomised trial assessing the effectiveness of two types of SLT for people with Parkinson's disease. Trials. 18: 397. PMID 28851443 DOI: 10.1186/S13063-017-2130-1 |
0.494 |
|
| 2016 |
Clarke CE, Patel S, Ives N, Rick CE, Woolley R, Wheatley K, Walker MF, Zhu S, Kandiyali R, Yao G, Sackley CM. Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB). Health Technology Assessment (Winchester, England). 20: 1-96. PMID 27580669 DOI: 10.3310/hta20630 |
0.398 |
|
| 2016 |
Mathers J, Rick C, Jenkinson C, Garside R, Pall H, Mitchell R, Bayliss S, Jones LL. Patients' experiences of deep brain stimulation for Parkinson's disease: a qualitative systematic review and synthesis. Bmj Open. 6: e011525. PMID 27338883 DOI: 10.1136/Bmjopen-2016-011525 |
0.418 |
|
| 2016 |
McIntosh E, Gray A, Daniels J, Gill S, Ives N, Jenkinson C, Mitchell R, Pall H, Patel S, Quinn N, Rick C, Wheatley K, Williams A. Cost-utility analysis of deep brain stimulation surgery plus best medical therapy versus best medical therapy in patients with Parkinson's: Economic evaluation alongside the PD SURG trial. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26846185 DOI: 10.1002/Mds.26423 |
0.357 |
|
| 2016 |
Muzerengi S, Herd C, Rick C, Clarke CE. A systematic review of interventions to reduce hospitalisation in Parkinson's disease. Parkinsonism & Related Disorders. 24: 3-7. PMID 26803377 DOI: 10.1016/J.Parkreldis.2016.01.011 |
0.434 |
|
| 2016 |
Clarke CE, Patel S, Ives N, Rick CE, Dowling F, Woolley R, Wheatley K, Walker MF, Sackley CM. Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical Trial. Jama Neurology. 73: 291-9. PMID 26785394 DOI: 10.1001/jamaneurol.2015.4452 |
0.38 |
|
| 2016 |
Muzerengi S, Herd C, Rick C, Clarke CE. Review of interventions to reduce hospitalisation in Parkinson's disease Parkinsonism & Related Disorders. 22. DOI: 10.1016/J.Parkreldis.2015.10.146 |
0.402 |
|
| 2016 |
Muzerengi S, Rick C, Begaj I, Ives N, Evison F, Woolley R, Clarke CE. Hospitalisation coding errors in Parkinson's disease in a large UK teaching hospital Parkinsonism & Related Disorders. 22. DOI: 10.1016/J.Parkreldis.2015.10.049 |
0.318 |
|
| 2016 |
Muzerengi S, Woolley R, Rick C, Ives N, Gray R, Dowling F, Clarke CE. Hospitalisation in early Parkinson's disease using Hospital Episodes Statistics from the PD MED trial Parkinsonism & Related Disorders. 22. DOI: 10.1016/J.Parkreldis.2015.10.048 |
0.505 |
|
| 2015 |
Stow R, Rushton A, Ives N, Smith C, Rick C. A cluster randomised feasibility trial evaluating six-month nutritional interventions in the treatment of malnutrition in care home-dwelling adults: recruitment, data collection and protocol. Pilot and Feasibility Studies. 1: 3. PMID 27965783 DOI: 10.1186/2055-5784-1-3 |
0.348 |
|
| 2015 |
Stow R, Ives N, Smith C, Rick C, Rushton A. A cluster randomised feasibility trial evaluating nutritional interventions in the treatment of malnutrition in care home adult residents. Trials. 16: 433. PMID 26416253 DOI: 10.1186/S13063-015-0952-2 |
0.333 |
|
| 2015 |
Jenkinson C, Clarke C, Gray R, Hewitson P, Ives N, Morley D, Rick C, Wheatley K, Williams A. Comparing results from long and short form versions of the Parkinson's disease questionnaire in a longitudinal study. Parkinsonism & Related Disorders. PMID 26360237 DOI: 10.1016/J.Parkreldis.2015.09.008 |
0.378 |
|
| 2015 |
Jenkinson C, Clarke C, Gray R, Hewitson P, Ives N, Morley D, Rick C, Wheatley K, Williams A. Comparing results from long and short form versions of the Parkinson's disease questionnaire in a longitudinal study Parkinsonism and Related Disorders. DOI: 10.1016/j.parkreldis.2015.09.008 |
0.3 |
|
| 2014 |
Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE. Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial. Lancet (London, England). 384: 1196-205. PMID 24928805 DOI: 10.1016/S0140-6736(14)60683-8 |
0.451 |
|
| 2014 |
Sackley CM, Smith CH, Rick C, Brady MC, Ives N, Patel R, Roberts H, Dowling F, Jowett S, Wheatley K, Patel S, Kelly D, Sands G, Clarke C. Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease (PD COMM pilot): study protocol for a randomized controlled trial. Trials. 15: 213. PMID 24908096 DOI: 10.1186/1745-6215-15-213 |
0.397 |
|
| 2014 |
Clarke C, Patel S, Woolley R, Ives N, Rick C, Wheatley K, Walker M, Sackley C. Pd Rehab Rct Of Physiotherapy And Ot In Parkinson'S Disease Journal of Neurology, Neurosurgery, and Psychiatry. 85. DOI: 10.1136/Jnnp-2014-309236.21 |
0.458 |
|
| 2013 |
Rick C, Patel S, Ives N, Dowling F, Daniels J, Gill S, Jenkinson C, Mitchell R, Pall H, Quinn N, Clarke C, Varma T, Wheatley K, Williams A. Does stimulus predict the best candidates for deep brain stimulation for PD Trials. 14: 114. DOI: 10.1186/1745-6215-14-S1-P114 |
0.45 |
|
| 2012 |
Clarke CE, Patel S, Ives N, Rick C, Jenkinson C, Wheatley K, Williams A, Gray R. 1.091 A Large Randomised Trial Assessing Quality Of Life In Patients With Early Pd: Results From Pd Med Early Parkinsonism & Related Disorders. 18. DOI: 10.1016/S1353-8020(11)70205-X |
0.454 |
|
| 2012 |
Jenkinson C, Williams A, Ives N, Rick C, Daniels J, Patel S, Wheatley K, Churchman D. PND41 Parkinson's Disease Questionnaire (PDQ-39) As a Primary Endpoint in a Trial Comparing Deep Brain Stimulation With Best Medical Therapy Versus Best Medical Therapy Alone for Advanced Parkinson's Disease (PD SURG TRIAL): A Randomised, Open-Label Trial Value in Health. 15. DOI: 10.1016/J.Jval.2012.03.800 |
0.491 |
|
| 2011 |
Clarke CE, Patel S, Ives N, Rick C, Wheatley K, Gray R. Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops? Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1187-93. PMID 21495068 DOI: 10.1002/Mds.23519 |
0.405 |
|
| 2010 |
Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease Movement Disorders. 25: 2649-2653. PMID 21069833 DOI: 10.1002/Mds.23429 |
0.405 |
|
| 2010 |
Williams A, Gill S, Varma T, Jenkinson C, Quinn N, Mitchell R, Scott R, Ives N, Rick C, Daniels J, Patel S, Wheatley K. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. The Lancet. Neurology. 9: 581-91. PMID 20434403 DOI: 10.1016/S1474-4422(10)70093-4 |
0.442 |
|
| 2009 |
Ives N, Patel S, Stowe R, Williams A, Rick C, Wheatley K. P2.140 Meta-analysis of DBS surgery in patients with advanced Parkinson's disease Parkinsonism & Related Disorders. 15. DOI: 10.1016/S1353-8020(09)70491-2 |
0.378 |
|
| 2009 |
Ives N, Patel S, Solanki V, Clarke C, Rick C, Gray R, Wheatley K. P2.139 Incidence and predictors of motor complications in the PD MED trial Parkinsonism & Related Disorders. 15. DOI: 10.1016/S1353-8020(09)70490-0 |
0.427 |
|
| 2009 |
Clarke C, Patel S, Solanki V, Ives N, Rick C, Gray R, Wheatley K. P2.125 Parkinson's disease treatments in practice: evidence from the PD MED trial Parkinsonism & Related Disorders. 15. DOI: 10.1016/S1353-8020(09)70476-6 |
0.514 |
|
| 2009 |
Rick C, Ives N, Patel S, Parsons S, Tomlinson C, Gill S, Varma T, Williams A, Wheatley K. P2.049 Beneflts and risks of deep brain stimulation (DBS) for Parkinson's disease (PD) – results from the PD SURG study Parkinsonism & Related Disorders. 15. DOI: 10.1016/S1353-8020(09)70400-6 |
0.463 |
|
| 2009 |
Patel S, Solanki V, Ives N, Clarke C, Rick C, Wheatley K, Gray R. P1.158 Incidence and predictors of dementia in the PD MED trial Parkinsonism & Related Disorders. 15. DOI: 10.1016/S1353-8020(09)70280-9 |
0.447 |
|
| 2009 |
Patel S, Solanki V, Ives N, Clarke C, Rick C, Wheatley K, Gray R. P1.157 Sensitivity to change of quality of life rating scales used in the PD MED trial Parkinsonism & Related Disorders. 15. DOI: 10.1016/S1353-8020(09)70279-2 |
0.416 |
|
| Show low-probability matches. |